APP
BLFS icon

Alpha Paradigm Partners’s BioLife Solutions BLFS Stock Holding History

Alpha Paradigm Partners’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14,234
Closed -$568K – 504
2020
Q4 		$568K Buy
+14,234
New +$485K 0.2% 132

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alpha Paradigm Partners's BLFS Position: Q1 2021 in Review

Alpha Paradigm Partners sold out of BioLife Solutions (BLFS) in Q1 2021, closing a stake of 14,234 shares — an estimated $568K sold.

Alpha Paradigm Partners first reported a position in BLFS in Q4 2020 and held it in 1 quarter. The position peaked at $568K in Q4 2020. 132 funds tracked by Wall St. Rank hold BLFS as of Q1 2021.

  • Alpha Paradigm Partners reported no remaining BioLife Solutions position as of Q1 2021 after selling out during the quarter.
  • Alpha Paradigm Partners sold 14,234 BioLife Solutions shares in Q1 2021, an estimated $568K.
  • Alpha Paradigm Partners first reported a position in BioLife Solutions in Q4 2020 and held it in 1 quarter.
  • Alpha Paradigm Partners's BioLife Solutions position peaked at $568K in Q4 2020.
  • 132 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2021.

Based on Alpha Paradigm Partners's 13F filing for Q1 2021, filed 14 May 2021.